Organogenesis Holdings Inc (NASDAQ: ORGO) is -32.27% lower on its value in year-to-date trading and has touched a low of $1.79 and a high of $4.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ORGO stock was last observed hovering at around $2.61 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $2.77, the stock is -1.60% and -13.94% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.89 million and changing 6.13% at the moment leaves the stock -11.83% off its SMA200. ORGO registered 30.05% gain for a year compared to 6-month loss of -6.73%. The firm has a 50-day simple moving average (SMA 50) of $0.83 and a 200-day simple moving average (SMA200) of $10.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -3.82% gain in the last 1 month and extending the period to 3 months gives it a -32.11%, and is 5.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.94% over the week and 6.75% over the month.
Organogenesis Holdings Inc (ORGO) has around 862 employees, a market worth around $365.53M and $433.14M in sales. Current P/E ratio is 75.48 and Fwd P/E is 33.24. Profit margin for the company is 1.14%. Distance from 52-week low is 54.32% and -41.13% from its 52-week high. The company has generated returns on investments over the last 12 months (1.31%).
Organogenesis Holdings Inc quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $101.05M over the same period.The EPS is expected to shrink by -93.45% this year, but quarterly earnings will post 5.00% year-over-year.
150 institutions hold shares in Organogenesis Holdings Inc (ORGO), with institutional investors hold 67.17% of the company’s shares. The shares outstanding are 131.32M, and float is at 77.46M with Short Float at 10.34%. Institutions hold 44.85% of the Float.
The top institutional shareholder in the company is Soleus Capital Management, L.P. with over 11.73 million shares valued at $38.94 million. The investor’s holdings represent 8.93% of the ORGO Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 4.85 million shares valued at $16.09 million to account for 3.69% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.63 million shares representing 2.76% and valued at over $12.04 million, while Millennium Management Llc holds 1.66% of the shares totaling 2.18 million with a market value of $7.23 million.
Organogenesis Holdings Inc (ORGO) Insider Activity
The most recent transaction is an insider sale by ERANI ALBERT, the company’s 10% Owner. SEC filings show that ERANI ALBERT sold 17,972 shares of the company’s common stock on Jan 10 ’24 at a price of $4.28 per share for a total of $76875.0. Following the sale, the insider now owns 59.01 million shares.
Organogenesis Holdings Inc disclosed in a document filed with the SEC on Jan 10 ’24 that ERANI ALBERT (10% Owner) sold a total of 17,972 shares of the company’s common stock. The trade occurred on Jan 10 ’24 and was made at $4.28 per share for $76875.0. Following the transaction, the insider now directly holds 59.01 million shares of the ORGO stock.
Still, SEC filings show that on Jan 09 ’24, ERANI ALBERT (10% Owner) disposed off 197,921 shares at an average price of $4.37 for $0.86 million. The insider now directly holds 59,025,106 shares of Organogenesis Holdings Inc (ORGO).
